Cases & Deals

VasoRx develops patent portfolios relating to lipid nanoparticles for RNA-based therapies

Client(s) VasoRX, Inc.

Jones Day is representing VasoRx, Inc. in connection with the development of patent portfolios relating lipid nanoparticles (LNP) and their use in the delivery of RNA-based therapeutics (e.g., RNAi, siRNA and miRNA) to endothelial cells for the treatment of vascular disorders, such as cardiovascular diseases and pulmonary arterial hypertension (PAH).